Combined Effects of Bioactive Compounds in Lipid Profile

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 118 participants.

Also called NCT01562080

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 118 participants (enrolled count) (from the registry)
Sponsor
Rottapharm Spain (from the registry)
Registry
  • NCT NCT01562080
Other papers using this trial's data
  • Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial PloS one, 2014 DOI, PubMed 25084280, PMC4118855 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01562080. Randomized; double masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2012-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Combined Effects of Bioactive Compounds in Lipid Profile
Acronym
ARM-PLUS-LDL
Condition
Hyperlipidemia
Condition
Low-density-lipoprotein-type
Condition
Elevated Triglycerides
Intervention (Dietary supplement)
Armolipid Plus
Intervention (Dietary supplement)
placebo
Lead sponsor
Rottapharm Spain (class: industry)
Collaborator
Centro Tecnológico de Nutrición y Salud (class: other)

Record details

Record id
cardio:ct-nct01562080
Content hash
5f97fb2fbdce529078609db960870ef6d74ecfcbdabbe2242399665b79dc0855